Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioharvest Sciences (BHST) FCF Margin (2023 - 2025)

Bioharvest Sciences has reported FCF Margin over the past 3 years, most recently at 69.58% for Q4 2025.

  • For Q4 2025, FCF Margin rose 3575.0% year-over-year to 69.58%; the TTM value through Dec 2025 reached 27.76%, up 1003.0%, while the annual FY2025 figure was 27.76%, 1003.0% up from the prior year.
  • FCF Margin was 69.58% for Q4 2025 at Bioharvest Sciences, down from 18.37% in the prior quarter.
  • Across five years, FCF Margin topped out at 12.44% in Q2 2024 and bottomed at 105.33% in Q4 2024.
  • The 3-year median for FCF Margin is 18.72% (2024), against an average of 32.18%.
  • Year-over-year, FCF Margin plummeted -4553bps in 2024 and then surged 3575bps in 2025.
  • Over 3 years, FCF Margin stood at 59.8% in 2023, then plummeted by -76bps to 105.33% in 2024, then skyrocketed by 34bps to 69.58% in 2025.
  • The last three reported values for FCF Margin were 69.58% (Q4 2025), 18.37% (Q3 2025), and 10.15% (Q2 2025) per Business Quant data.